40 Participants Needed

Exercise Rehabilitation for Peripheral Neuropathy

(EX-CIPN Trial)

EA
Overseen ByEric Antonen
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: University Health Network, Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to learn if the EX-CIPN exercise-based intervention is feasible, acceptable, and safe in participants with persistent chemotherapy-induced peripheral neuropathy (CIPN). It will also give insight on the effectiveness of the exercise intervention in treating CIPN symptoms. The main questions it aims to answer are: * Is EX-CIPN safe, acceptable, and feasible in cancer survivors experiencing persistent CIPN? * Are the study design and methods feasible (recruitment and retention rates, feasibility of data collection and procedures)? Researchers will provide all participants with the exercise-based intervention. Participants will: * Complete assessments at baseline, immediately post-intervention, and 3-months post-intervention * Complete a 10-week remote, individualized exercise program * Receive health coaching calls on weeks 2, 3, 4, 6, and 8 of the intervention * Wear a FitBit throughout the study to track physical activity and promote behaviour change

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking ado-trastuzumab emtansine (TDM1).

What data supports the effectiveness of the treatment EX-CIPN for peripheral neuropathy?

Research shows that exercise therapy can improve symptoms and physical function in people with diabetic neuropathy, and specific exercise regimens can enhance balance and confidence in those with peripheral neuropathy. Additionally, tai chi, a form of exercise, has been found to increase strength, balance, and stamina in older adults with peripheral neuropathy.12345

Is exercise rehabilitation safe for people with peripheral neuropathy?

Research on exercise-based rehabilitation for chemotherapy-induced peripheral neuropathy suggests it is generally safe for humans, as it is often included in integrated programs with other therapies like massage and passive mobilization.678910

How is the EX-CIPN treatment different from other treatments for peripheral neuropathy?

EX-CIPN is unique because it focuses on exercise-based rehabilitation to manage peripheral neuropathy, which is different from traditional drug treatments. It aims to improve strength, stamina, and sensation through physical activity, offering a non-drug approach to reduce symptoms and enhance quality of life.124611

Eligibility Criteria

This trial is for cancer survivors who are dealing with persistent chemotherapy-induced peripheral neuropathy (CIPN). Participants should be willing to engage in a 10-week exercise program, receive health coaching calls, and wear a FitBit. Specific eligibility criteria were not provided.

Inclusion Criteria

Currently engaging in < 90min per week of planned moderate-intensity aerobic exercise
I finished chemotherapy more than 6 months ago.
I have nerve damage from chemotherapy.
See 8 more

Exclusion Criteria

Currently enrolled in other cancer rehabilitation or exercise-based programs/interventions
I am currently on Kadcyla (TDM1) treatment.
I had nerve damage before starting chemotherapy.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants complete a 10-week remote, individualized exercise program with health coaching calls and Fitbit monitoring

10 weeks
5 health coaching calls (weeks 2, 3, 4, 6, and 8)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at baseline, immediately post-intervention, and 3-months post-intervention

14 weeks
3 assessment visits (baseline, post-intervention, 3-months post-intervention)

Treatment Details

Interventions

  • EX-CIPN
Trial Overview The EX-CIPN intervention being tested involves an individualized exercise program designed to treat symptoms of CIPN. The study will assess the safety, acceptability, and feasibility of this approach through participant assessments at various stages.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: EX-CIPN Exercise- Based interventionExperimental Treatment1 Intervention
This arm is provided with an intervention that includes an individualized exercise program, remote monitoring, and remote person-to-person clinical support.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Health Network, Toronto

Lead Sponsor

Trials
1,555
Recruited
526,000+

Findings from Research

Exercise therapy may provide short-term benefits in reducing neuropathic symptoms and improving physical function in people with diabetic neuropathy, based on a review of 11 randomized clinical trials involving 517 participants.
However, the overall quality of evidence supporting these benefits is very low, and no significant effects were observed on psychosocial aspects of health.
Effects of exercise therapy on diabetic neuropathy: A systematic review and meta-analysis.Hernando-Garijo, I., Medrano-de-la-Fuente, R., Mingo-Gómez, MT., et al.[2023]
The study involved 10 adults with diabetic peripheral neuropathy (DPN) who participated in a 4-week intervention aimed at promoting physical activity self-management, which included exercise tasters and behavior change counseling.
Participants experienced significant reductions in foot symptoms, specifically aching and burning pain, after the intervention, with no major adverse events reported, indicating that the Physical Activity Intelligence (PAI) self-monitoring approach is both safe and potentially effective.
Personal Activity Intelligence eHealth intervention in people with diabetic peripheral neuropathy: A feasibility study.Coombes, BK., Bisset, LM., Sierra-Silvestre, E., et al.[2023]
A 12-week tai chi program led to long-term engagement in exercise for older adults with peripheral neuropathy, with participants continuing classes for an additional 18 months, highlighting the importance of psychosocial support in maintaining exercise routines.
Participants showed significant improvements in strength, balance, and stamina, confirming the physical benefits of tai chi, although changes in quality of life scores were not statistically significant, qualitative feedback indicated meaningful improvements.
Impact of Tai Chi on Peripheral Neuropathy Revisited: A Mixed-Methods Study.Hermanns, M., Haas, BK., Rath, L., et al.[2020]

References

Effects of exercise therapy on diabetic neuropathy: A systematic review and meta-analysis. [2023]
Personal Activity Intelligence eHealth intervention in people with diabetic peripheral neuropathy: A feasibility study. [2023]
Impact of Tai Chi on Peripheral Neuropathy Revisited: A Mixed-Methods Study. [2020]
Integrated Exercise and Glycemic and Peripheral Sensation Control in Diabetic Neuropathy: A Single-Blind, Randomized Controlled Trial. [2022]
A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. [2022]
Effects of exercise interventions to reduce chemotherapy-induced peripheral neuropathy severity: A meta-analysis. [2023]
Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy. [2021]
A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises. [2020]
Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheral neuropathy in adolescents: A preliminary study. [2019]
Exercise for people with peripheral neuropathy. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security